Mettler-Toledo International Inc. (MTD): Health Care's Highlighted Dud Of The Day

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Mettler-Toledo International ( MTD) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.4%. By the end of trading, Mettler-Toledo International fell $3.59 (-1.7%) to $209.53 on average volume. Throughout the day, 210,050 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 157,800 shares. The stock ranged in price between $207.33-$211.51 after having opened the day at $210 as compared to the previous trading day's close of $213.12. Other companies within the Health Care sector that declined today were: Durata Therapeutics ( DRTX), down 15.6%, Genvec ( GNVC), down 13%, Synergy Pharmaceuticals ( SGYP), down 11.5%, and Integra LifeSciences Holdings ( IART), down 11.1%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Mettler-Toledo International has a market cap of $6.31 billion and is part of the health services industry. The company has a P/E ratio of 22.8, above the S&P 500 P/E ratio of 17.7. Shares are up 10.3% year to date as of the close of trading on Wednesday. Currently there are four analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, ACADIA Pharmaceuticals ( ACAD), up 64.4%, Redhill Biopharma ( RDHL), up 17%, Biolase ( BIOL), up 13.3%, and Coronado Biosciences ( CNDO), up 11.2%, were all gainers within the health care sector with Celgene Corporation ( CELG) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.